Stay updated on ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial

Sign up to get notified when there's something new on the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of a Phase 1-2 clinical trial involving ADXS11-001 or MEDI4736 alone or in combination for cervical or HPV+ head & neck cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:49:30.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for study participants, including specific health conditions and prior treatments required for inclusion. Previously, this section only indicated that no information was provided.
    Difference
    21%
    Check dated 2024-05-22T21:38:09.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:37:12.000Z thumbnail image

Stay in the know with updates to ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADXS11-001 & MEDI4736 Combo in HPV+ Cancer Clinical Trial page.